Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (FDA) for nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/g, the generic version of Mycolog-II ... PharmaBiz, 1 month ago
Glenmark receives approval for Nystatin Cream - HT Syndication, 1 month ago
Glenmark receives USFDA approval for generic version of Mycolog-II - HT Syndication, 1 month ago
2 images for "glenmark generics inc"
TRIAMCINOLONE ACETONIDE CREAM USP, 0.1% MARKETED BY: Glenmark Pharmaceuticals, Inc COMPARE TO: Kenalog Cream, 0.1% (Delcor Asset Corporation) INDICATION: Glenmark Pharmaceuticals, Inc, has been granted final approval by the FDA for Triamcinolone ...Pharmacy Times, 1 month ago Generic Product News (November 2016) » Pharmacy Times, 3 weeks ago Glenmark Pharma gets ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g India Infoline, 1 month ago 10/25/16 - Glenmark Pharma gets ANDA approval for Nystatin and Triamcinolone Acetonide Cream [India Infoline News Service] Pharmacy Choice, 1 month ago
Glenmark Pharmaceuticals today said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers. The agreement for ...Business Standard, 2 months ago
This week saw Glenmark Pharmaceuticals cons revenue up by 16% in Q2 FY17, Sun Pharmaceutical launched 4 generics in US. IIFL presents a weekly snapshot of all the major happenings in the Pharmaceuticals industry, nationally and internationally. ...India Infoline, 1 month ago
Dr. Stoeckli will lead the company's global research portfolio consisting of NBE, NCE, generics and branded formulations. He will be responsible for sustaining and enhancing the environment of collaborative research and for driving successful ...India Infoline, 1 month ago Glenmark appoints Dr Kurt Stoeckli as president & CSO PharmaBiz, 1 month ago
D. Del. (2016) On August 31, 2016, Judge Richard G. Andrews of the District of Delaware ruled in favor of Fitzpatrick's client Sanofi,upholding the validity of U.S. Patent No. 8,410,167. The 167 patent is directed to the use of Sanofi's Multaq® ...Fitzpatrickcella.com, 3 weeks ago GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. JD Supra, 3 weeks ago Sanofi v. Glenmark Pharms. Inc. JD Supra, 1 month ago
The biggest sectoral loser on Friday is the Nifty Pharma index, with all its ten constituents trading in the red, with losses of between 0.5-6 percent, reacting to a generic drug price probe that has been initiated by in the U.S.. The first charges ...Bloomberg-Quint, 1 month ago Range bound trading continues; pharma shares edge higher Business Standard India, 3 weeks ago Indian pharmaceutical companies shares crash after reports of US probe into price collusion The American Bazaar, 1 month ago Pharma stocks slide over US probe reports; Sun Pharma falls 7.41% Livemint.com, 1 month ago
Global Digital Dose Inhaler (Branded Medication, Generics Medication) Market 2016-2024: Focus on Metered Dose Inhalers & Dry Powder Inhalers - Research and Markets
/PRNewswire/ -- has announced the addition of the report to their offering. The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024 The key factors contributing to the lucrative growth of this market ...International Business Times, 2 months ago Global Market for Pain Management - What's hot, what's not, what's next by coming years? Before It's News, 1 week ago Anti-Infective Agents - Global Market Outlook (2016-2022) MarketResearch.com, 4 weeks ago Market Research on Erythema Multiforme Global Clinical Trials Review, H2, 2016 MyNewsDesk, 1 month ago
DR.REDDY'S LABORATORIES LTD : Blog Coverage Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
/ Active Wall St. blog coverage looks at the headline from Dr. Reddy's Laboratories Ltd (NYSE: RDY ) as the company announced on November 11, 2016, that it had launched a generic Osteoporosis drug, raloxifene hydrochloride, in tablet form in the US.4 Traders, 3 weeks ago Blog Coverage Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US Yahoo! Finance, 3 weeks ago
About the PTAB Life Sciences Report: Each month we will report on developments at the PTAB involving life sciences patents. Mylan Pharmaceuticals Inc. v. Shire Laboratories, Inc. PTAB Petition: IPR2017-00011; filed October 4, 2016. Patent at ...JD Supra, 1 day ago PTAB Life Sciences Report - October 2016 JD Supra, 1 month ago
on your WebpageAdd Widget >Get your members hooked!